PHINIA INC. shareholders approved Advisory vote on executive compensation at the 2026-05-22 meeting.
“Proposal 2. The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers.”
Results of shareholder votes disclosed under 8-K Item 5.07.
PHINIA INC. shareholders approved Advisory vote on executive compensation at the 2026-05-22 meeting.
“Proposal 2. The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers.”
PHINIA INC. shareholders approved Election of eight nominees as directors at the 2026-05-22 meeting.
“Proposal 1. The shareholders elected the following eight nominees as directors of the Company to hold office until the next annual meeting of shareholders and until their respective successors are duly elected and qualified.”
Ondas Inc. shareholders approved Amendment to 2021 Plan to increase authorized shares for issuance.
“Proposal 5 - a proposal to approve an amendment to the 2021 Plan to increase the number of shares of Common Stock authorized for issuance under the 2021 Plan.”
Ondas Inc. shareholders approved Amendment to increase authorized shares from 800,000,000 to 1,200,000,000.
“Proposal 4 - a proposal to approve an amendment to the Company’s Amended and Restated Articles of Incorporation, as amended, to increase the number of authorized shares of common stock from 800,000,000 to 1,200,000,000 (the “Certificate of Amendment”).”
Ondas Inc. shareholders approved Advisory approval of executive compensation.
“Proposal 3 - a proposal to obtain advisory approval of the Company’s executive compensation.”
Ondas Inc. shareholders approved Ratify selection of BDO USA, P.C. as independent auditors at the 2026-12-31 meeting.
“Proposal 2 - a proposal to ratify the selection of BDO USA, P.C. as the Company’s independent certified public accountants for the fiscal year ending December 31, 2026.”
Ondas Inc. shareholders approved Election of four directors.
“Proposal 1 - a proposal to elect four directors, each for a term expiring at the next annual meeting or until their successors are duly elected and qualified.”
Crane NXT, Co. shareholders approved Advisory vote on executive compensation at the 2026-05-21 meeting.
“Proposal 3 The stockholders approved, on an advisory basis, the compensation of the named executive officers as disclosed in the Company’s definitive proxy statement filed with the United States Securities and Exchange Commission on April 7, 2026. For Against Abstain Broker non-votes 50,192,899 858,661 589,019 2,171,684”
Crane NXT, Co. shareholders approved Ratification of Deloitte & Touche LLP as independent auditors for the Company for 2026 at the 2026-05-21 meeting.
“Proposal 2 The stockholders ratified the selection of Deloitte & Touche LLP as independent auditors for the Company for 2026. For Against Abstain Broker non-votes 53,307,949 108,480 395,834 0”
Crane NXT, Co. shareholders approved Election of nine directors to serve until the 2027 Annual Meeting of Stockholders at the 2026-05-21 meeting.
“Proposal 1 The following nine Directors were elected to serve until the 2027 Annual Meeting of Stockholders: Director Nominee For Against Abstain Broker non-votes Jeff Benck 51,338,444 238,870 63,265 2,171,684 Michael Dinkins 50,681,757 894,852 63,970 2,171,684 William Grogan 50,896,270 687,639 56,670 2,171,684 Sandra Joyce 50,895,132 688,970 56,477 2,171,684 Cristen Kogl 50,805,775 771,601 63,203 2,171,684 Ellen McClain 50,404,790 1,138,302 97,487 2,171,684 David D. Petratis 49,903,997 1,640,689 95,893 2,171,684 Aaron W. Saak 50,877,896 706,079 56,604 2,171,684 John S. Stroup 50,834,708 748,128 57,743 2,171,684”
TWFG, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-27 meeting.
“FOR AGAINST ABSTAIN 352,121,435 28,096 50,625”
TWFG, Inc. shareholders approved Election of Directors at the 2026-05-27 meeting.
“NOMINEES FOR WITHHELD BROKER NON-VOTES Richard F. ("Gordy") Bunch III 349,827,885 857,720 1,514,551 Michael Doak 348,197,964 2,487,641 1,514,551 Jonathan Anderson 348,767,265 1,918,340 1,514,551 Michelle Caroline Bunch 346,229,963 4,455,642 1,514,551 Robin A. Ferracone 350,002,933 682,672 1,514,551 Janet S. Wong 350,002,932 682,673 1,514,551”
TEVA PHARMACEUTICAL INDUSTRIES LTD shareholders approved Ratification of appointment of Kesselman & Kesselman (PricewaterhouseCoopers) as independent registered public accounting firm at the 2026-05-28 meeting.
“The shareholders approved the appointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva’s independent registered public accounting firm until Teva’s 2027 annual meeting of shareholders, as follows: For Against Abstain Broker non-votes 880,542,242 36,085,507 525,382 0”
TEVA PHARMACEUTICAL INDUSTRIES LTD shareholders approved Advisory (non-binding) vote on compensation for named executive officers at the 2026-05-28 meeting.
“The shareholders approved, on a non-binding advisory basis, the compensation for Teva’s named executive officers listed in the proxy statement for the Annual Meeting, as follows: For Against Abstain Broker non-votes 795,976,042 77,082,847 1,170,026 50,661,570”
TEVA PHARMACEUTICAL INDUSTRIES LTD shareholders approved Election of Director to serve until Teva's 2029 annual meeting at the 2026-05-28 meeting.
“The shareholders elected to appoint the following person to the Board, to serve until Teva’s 2029 annual meeting of shareholders, as follows: For Against Abstain Broker non-votes Dr. Sol J. Barer 627,816,662 245,921,571 530,682 50,661,570”
SPORTSMAN'S WAREHOUSE HOLDINGS, INC. shareholders approved Advisory vote on frequency of future advisory votes on named executive officer compensation (1 year) at the 2026-05-27 meeting.
“Proposal 5 : The Company’s stockholders approved, on an advisory basis, a 1 year frequency for future advisory votes on named executive officer compensation. 1 Year 2 Years 3 Years Abstain Broker Non-Votes 22,679,969 63,766 698,101 16,381 7,228,362”
SPORTSMAN'S WAREHOUSE HOLDINGS, INC. shareholders approved Ratification of appointment of Grant Thornton LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-05-27 meeting.
“Proposal 4 : The Company’s stockholders ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for fiscal year 2026. For Against Abstain Broker Non-Votes 30,510,219 149,177 27,183 —”
SPORTSMAN'S WAREHOUSE HOLDINGS, INC. shareholders approved Approval of second amendment and restatement of the Amended 2019 Plan, including to increase the number of shares available for grant at the 2026-05-27 meeting.
“Proposal 3 : The Company’s stockholders approved a second amendment and restatement of the Amended 2019 Plan, including to increase the number of shares available for grant under the Amended 2019 Plan. For Against Abstain Broker Non-Votes 18,869,207 4,422,440 166,570 7,228,362”
SPORTSMAN'S WAREHOUSE HOLDINGS, INC. shareholders approved Advisory vote on named executive officer compensation at the 2026-05-27 meeting.
“Proposal 2 : The Company’s stockholders approved, on an advisory basis, the Company’s named executive officer compensation. For Against Abstain Broker Non-Votes 21,391,384 1,409,389 657,444 7,228,362”
SPORTSMAN'S WAREHOUSE HOLDINGS, INC. shareholders approved Election of Directors at the 2026-05-27 meeting.
“Proposal 1 : The Company’s stockholders elected the six individuals below to serve on the Board until the Company’s 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal. Nominee For Against Abstain Broker Non-Votes Martha Bejar 20,395,501 3,014,989 47,727 7,228,362 Richard McBee 22,616,715 793,819 47,683 7,228,362 Steven Sansom 22,605,746 803,763 48,708 7,228,362 Paul Stone 22,785,678 603,397 69,142 7,228,362 Michael Tucci 23,245,162 162,868 50,187 7,228,362 Nancy A. Walsh 22,748,950 195,258 514,009 7,228,362”
Esquire Financial Holdings, Inc. shareholders approved Advisory vote on executive compensation (Say-on-Pay) at the 2026-05-28 meeting.
“For Against Abstain Broker Non-votes 6,055,238 164,334 10,459 1,395,317”
Esquire Financial Holdings, Inc. shareholders approved Ratification of Crowe LLP as independent registered public accounting firm at the 2026-05-28 meeting.
“For Against Abstain Broker Non-votes 7,472,223 17,282 135,843 —”
Esquire Financial Holdings, Inc. shareholders approved Election of Directors (three-year term) at the 2026-05-28 meeting.
“For a three-year term For Withheld Broker Non-Votes Raymond Kelly 6,165,991 64,040 1,395,317 Robert J. Mitzman 4,873,358 1,356,673 1,395,317 Kevin C. Waterhouse 5,879,631 350,400 1,395,317 For a two-year term For Withheld Broker Non-Votes Todd Deutsch 5,968,414 261,617 1,395,317”
CORCEPT THERAPEUTICS INC shareholders approved Approval of amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan at the 2026-05-21 meeting.
“Proposal 4 - The amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan was approved. For 53,163,364 Against 23,867,363 Abstain 263,730 Broker Non-Votes 15,975,718”
CORCEPT THERAPEUTICS INC shareholders approved Advisory approval of the compensation of named executive officers at the 2026-05-21 meeting.
“Proposal 3 - The compensation of named executive officers was approved, on an advisory basis. For 72,511,429 Against 4,560,385 Abstain 222,643 Broker Non-Votes 15,975,718”
CORCEPT THERAPEUTICS INC shareholders approved Ratify the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-21 meeting.
“Proposal 2 - The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified. For 92,656,473 Against 569,010 Abstain 44,692 Broker Non-Votes —”
CORCEPT THERAPEUTICS INC shareholders approved Election of eight directors to hold office until 2027 annual meeting at the 2026-05-21 meeting.
“Proposal 1 - Election of Directors. The following directors were elected to serve until the Company’s 2027 annual meeting of stockholders. Director For Withheld Broker Non-Votes Gregg Alton 67,977,943 9,316,514 15,975,718 G. Leonard Baker, Jr. 64,912,506 12,381,951 15,975,718 Joseph K. Belanoff, M.D. 76,965,512 328,945 15,975,718 David L. Mahoney 51,078,278 26,216,179 15,975,718 Joshua M. Murray 76,753,606 540,851 15,975,718 Kimberly Park 70,288,833 7,005,624 15,975,718 Daniel N. Swisher, Jr. 67,594,098 9,700,359 15,975,718 James N. Wilson 72,730,017 4,564,440 15,975,718”
BANCFIRST CORP /OK/ shareholders approved Advisory vote to approve executive compensation at the 2026-05-28 meeting.
“Advisory vote to approve executive compensation”
BANCFIRST CORP /OK/ shareholders approved To ratify the selection of Forvis Mazars, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-28 meeting.
“To ratify the selection of Forvis Mazars, LLP as our independent registered public accounting firm for the fical year ending December 31, 2026”
BANCFIRST CORP /OK/ shareholders approved Election of the 17 directors nominated by the Board of Directors at the 2026-05-28 meeting.
“On May 28, 2026, BancFirst Corporation (the “Company”) held its annual meeting of shareholders.”
NEUROCRINE BIOSCIENCES INC shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-27 meeting.
“Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Abstentions Broker Non-votes 83,880,185 6,170,483 67,957 — The appointment of Ernst & Young LLP was ratified.”
NEUROCRINE BIOSCIENCES INC shareholders approved Approval of the Amended 2025 Plan at the 2026-05-27 meeting.
“Approval of the Amended 2025 Plan. Votes For Votes Against Abstentions Broker Non-votes 79,131,622 5,568,926 65,732 5,352,345 The Amended 2025 Plan was approved.”
NEUROCRINE BIOSCIENCES INC shareholders approved An advisory vote on the compensation paid to the Company's named executive officers at the 2026-05-27 meeting.
“An advisory vote on the compensation paid to the Company's named executive officers. Votes For Votes Against Abstentions Broker Non-votes 78,993,894 5,669,155 103,231 5,352,345 The compensation of the Company's named executive officers, as disclosed in the Proxy Statement, was approved on an advisory basis.”
NEUROCRINE BIOSCIENCES INC shareholders approved Election of three Class III Directors for a term of three years expiring at the 2029 Annual Meeting of Stockholders at the 2026-05-27 meeting.
“Election of three Class III Directors for a term of three years expiring at the 2029 Annual Meeting of Stockholders. Votes For Votes Withheld Broker Non-votes Kevin C. Gorman, Ph.D. 76,228,063 8,538,217 5,352,345 Gary A. Lyons 75,278,705 9,487,575 5,352,345 Johanna Mercier 74,671,942 10,094,338 5,352,345 The three nominees for Class III Director were elected.”
NexMetals Mining Corp. shareholders approved Approval of omnibus equity incentive plan at the 2026-05-27 meeting.
“Resolution #3 To consider and, if thought advisable, pass, with or without variation, an ordinary resolution confirming and approving the Company’s omnibus equity incentive plan. Number of Votes Percentage of Votes Votes in Favour 10,710,691 93.53% Votes Against 741,185 6.47%”
NexMetals Mining Corp. shareholders approved Appointment of independent auditor and authorization to fix remuneration at the 2026-05-27 meeting.
“Resolution #2 To appoint the independent auditor of the Company for the ensuing year and to authorize the directors of the Company to fix the remuneration to be paid to the auditor. Number of Votes Percentage of Votes Votes in Favour 11,439,537 99.89% Votes Withheld 12,339 0.11%”
NexMetals Mining Corp. shareholders approved Election of eight directors at the 2026-05-27 meeting.
“Resolution #1 To elect eight (8) directors of the Company for the ensuing year. Name Votes For Percentage For Votes Withheld Percentage Withheld Paul Martin 10,886,408 95.06% 565,468 4.94% Mark Christensen 10,889,013 95.08% 562,863 4.92% Jason LeBlanc 10,889,013 95.08% 562,863 4.92% Keith Marshall 10,886,408 95.06% 565,468 4.94% Warwick Morley-Jepson 10,886,208 95.06% 565,668 4.94% André van Niekerk 10,885,858 95.06% 566,018 4.94% Philipa Varris 10,885,858 95.06% 566,018 4.94% Sean Whiteford 10,888,663 95.08% 563,213 4.92%”
KOPIN CORP shareholders approved Advisory vote to approve compensation of named executive officers..
“4. APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS. An advisory vote to approve the compensation of the Company’s named executive officers was approved by the following votes: Votes For Votes Against Abstain Broker Non-Votes 68,891,995 879,772 288,803 44,251,551”
KOPIN CORP shareholders approved Ratification of appointment of BDO USA, P.C. as independent registered public accounting firm for fiscal year ending December 26, 2026. at the 2026-12-26 meeting.
“3. RATIFICATION OF APPOINTMENT OF BDO USA, P.C.AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 26, 2026. A proposal to ratify the appointment of BDO USA, P.C . as the independent registered public accounting firm of the Company for the current fiscal year was approved by the following votes: Votes For Votes Against Abstain Broker Non-Votes 112,844,182 1,223,442 244,497 —”
KOPIN CORP shareholders approved Approval of the Amended and Restated Kopin Corporation 2020 Equity Incentive Plan..
“2. APPROVAL OF THE AMENDED AND RESTATED 2020 EQUITY INCENTIVE PLAN. Votes For Votes Against Abstain Broker Non-Votes 68,660,986 849,750 549,834 44,251,551”
KOPIN CORP shareholders approved Election of directors: Jill J. Avery, Michael Murray, David Nieuwsma, Margaret Seif, Paul V. Walsh Jr..
“1. ELECTION OF DIRECTORS Jill J. Avery, Michael Murray, David Nieuwsma, Margaret Seif and Paul Walsh Jr. were all elected to serve as directors of the Company each for a term expiring at the Company’s 2027 Annual Meeting and until their successors are duly elected and qualified. The results of the election of directors are below. Nominee Votes For Votes Against Abstentions Broker Non-Votes Jill J. Avery 69,327,462 688,359 44,749 44,251,551 Michael Murray 69,720,247 301,272 39,051 44,251,551 David Nieuwsma 69,371,283 590,168 99,119 44,251,551 Margaret Seif 69,601,949 403,625 54,996 44,251,551 Paul V. Walsh Jr. 69,348,820 616,606 95,144 44,251,551”
LENNOX INTERNATIONAL INC shareholders approved Ratification of appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal year 2026 at the 2026-05-21 meeting.
“3. Ratification of appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal year 2026 32,108,994 8,961 14,681 0”
LENNOX INTERNATIONAL INC shareholders approved Advisory vote on the compensation of the Company’s named executive officers at the 2026-05-21 meeting.
“2. Advisory vote on the compensation of the Company’s named executive officers 28,795,108 516,686 30,584 2,790,257”
LENNOX INTERNATIONAL INC shareholders approved Election of three director nominees to serve as Class I directors, for a term that expires at the annual meeting of stockholders in 2029 at the 2026-05-21 meeting.
“1. Election of three director nominees to serve as Class I directors, for a term that expires at the annual meeting of stockholders in 2029 John W. Norris, III 27,631,287 1,701,895 9,196 2,790,257 Karen H. Quintos 27,331,816 1,996,509 14,053 2,790,257 Shane D. Wall 28,963,545 364,287 14,546 2,790,257”
FIVE STAR BANCORP shareholders approved Ratification of Selection of Baker Tilly US LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2026 at the 2026-05-21 meeting.
“On May 21, 2026, the Company held its Annual Meeting; 19,281,004 shares were represented by proxies or voted at the Annual Meeting, or 90.20% of the total shares outstanding. At the Annual Meeting, shareholders elected all of the 10 director nominees named in the Company’s 2026 Proxy Statement for a one-year term until the 2027 Annual Meeting of Shareholders and to serve until his or her successor is elected and qualified; and ratified the appointment of Baker Tilly US LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026. Final voting results from the Annual Meeting are as follows: Item 1 – Election of Directors Nominee For Withheld Broker Non-Votes Robert T. Perry Smith 16,928,021 123,539 2,229,444 Randall E. Reynoso 16,948,374 103,186 2,229,444 Larry E. Allbaugh 16,710,654 340,906 2,229,444 James E. Beckwith 17,027,202 24,358 2,229,444 Shannon Deary-Bell 17,015,121 36,439 2,229,444 Warren P. Kashiwagi 16,948,319 103,241 2,229”
FIVE STAR BANCORP shareholders approved Election of Directors at the 2026-05-21 meeting.
“On May 21, 2026, the Company held its Annual Meeting; 19,281,004 shares were represented by proxies or voted at the Annual Meeting, or 90.20% of the total shares outstanding. At the Annual Meeting, shareholders elected all of the 10 director nominees named in the Company’s 2026 Proxy Statement for a one-year term until the 2027 Annual Meeting of Shareholders and to serve until his or her successor is elected and qualified; and ratified the appointment of Baker Tilly US LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026. Final voting results from the Annual Meeting are as follows: Item 1 – Election of Directors Nominee For Withheld Broker Non-Votes Robert T. Perry Smith 16,928,021 123,539 2,229,444 Randall E. Reynoso 16,948,374 103,186 2,229,444 Larry E. Allbaugh 16,710,654 340,906 2,229,444 James E. Beckwith 17,027,202 24,358 2,229,444 Shannon Deary-Bell 17,015,121 36,439 2,229,444 Warren P. Kashiwagi 16,948,319 103,241 2,229”
BEL FUSE INC /NJ shareholders rejected A shareholder proposal to provide Class A Common Shareholders with the right to convert their shares into Class B Common Stock at the 2026-05-26 meeting.
“Proposal 5: A shareholder proposal to provide Class A Common Shareholders with the right to convert their shares into Class B Common Stock. This proposal was rejected by the following votes: For Against Abstentions Broker Non-Votes 736,905 1,016,457 2,539 158,418”
BEL FUSE INC /NJ shareholders approved The approval of the 2026 Equity Compensation Plan (previously approved by the board of directors of the Company) (the "2026 Plan") at the 2026-05-26 meeting.
“Proposal 4: The approval of the 2026 Equity Compensation Plan (previously approved by the board of directors of the Company) (the "2026 Plan"). This proposal was approved by the following votes: For Against Abstentions Broker Non-Votes 1,571,450 13,739 170,712 158,418”
BEL FUSE INC /NJ shareholders approved The approval, on an advisory basis, of the executive compensation of the Company's named executive officers at the 2026-05-26 meeting.
“Proposal 3: The approval, on an advisory basis, of the executive compensation of the Company's named executive officers. This proposal was approved by the following votes: For Against Abstentions Broker Non-Votes 1,564,823 20,528 170,550 158,418”
BEL FUSE INC /NJ shareholders approved The ratification of the designation of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026 at the 2026-05-26 meeting.
“Proposal 2: The ratification of the designation of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026. This proposal was approved by the following votes: For Against Abstentions 1,785,986 428 127,905”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.